YAZ Post-marketing Surveillance in Japan
Drug Use Investigation of YAZ
Sponsor: Bayer
This observational or N/A phase trial investigates Dysmenorrhea and is currently completed. Bayer leads this study, which shows 11 recorded versions since 2011 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
Apr 2019 — Jan 2021 [monthly]
Completed
-
Jun 2018 — Apr 2019 [monthly]
Completed
▶ Show 6 earlier versions
-
May 2018 — Jun 2018 [monthly]
Completed
Status: Active Not Recruiting → Completed
-
Apr 2018 — May 2018 [monthly]
Active Not Recruiting
Phase: NA → None
-
Mar 2018 — Apr 2018 [monthly]
Active Not Recruiting NA
-
Jul 2017 — Mar 2018 [monthly]
Active Not Recruiting NA
-
Feb 2017 — Jul 2017 [monthly]
Active Not Recruiting NA
Phase: PHASE4 → NA
-
Jan 2017 — Feb 2017 [monthly]
Active Not Recruiting PHASE4
First recorded
Jun 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Bayer
For direct contact, visit the study record on ClinicalTrials.gov .